High | P01132 | Pro-epidermal growth factor OS=Mus musculus OX=10090 GN=Egf PE=1 SV=2 | 0.004 | 3.033 | 2 | 1 | 1 | 1 | 1217 | 133 | 6.46 | | | 1 | | | 1 | | | 311305.25 | | | 1 | | metabolic process;regulation of biological process;response to stimulus;transport | extracellular;membrane | catalytic activity;metal ion binding;protein binding;receptor activity;signal transducer activity | "Pf00008, Pf00058, Pf07645, Pf12662, Pf12947, Pf14670" | 13645 | ENSMUSG00000028017.7 | Egf | 3 | "EGFR interacts with phospholipase C-gamma; Downregulation of ERBB2 signaling; GAB1 signalosome; EGFR downregulation; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; ERBB2 Regulates Cell Motility; SHC1 events in EGFR signaling; Interleukin-20 family signaling; Signaling by ERBB4; PI3K events in ERBB2 signaling; RAF/MAP kinase cascade; GRB2 events in EGFR signaling; ERBB2 Activates PTK6 Signaling; Platelet degranulation ; Cargo recognition for clathrin-mediated endocytosis; SHC1 events in ERBB2 signaling" | ErbB signaling pathway; FoxO signaling pathway; Endocytosis; Phospholipase D signaling pathway; Regulation of actin cytoskeleton; MAPK signaling pathway; Ras signaling pathway; Focal adhesion; Endometrial cancer; Breast cancer; Melanoma; Non-small cell lung cancer; Rap1 signaling pathway; HIF-1 signaling pathway; Pathways in cancer; Hepatitis C; Pancreatic cancer; PI3K-Akt signaling pathway; Gap junction; Glioma; EGFR tyrosine kinase inhibitor resistance; Choline metabolism in cancer; Cytokine-cytokine receptor interaction; Prostate cancer; Bladder cancer | 0 |